 Back in 2019, the Zolgensma approval validated Regenxbios NAV technology platform for gene delivery. Despite a slow start, Zolgensma recently hit 1B in cumulative sales. Regenxbios organic pipeline is advancing rapidly with RGX-314. And, you can expect an early data release in the next few months. 